| Cafepharma

You are here

Primary tabs

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions

Post date: November 14, 2024 - 7:28pm

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool

Post date: October 10, 2024 - 3:14pm

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition

Post date: March 26, 2024 - 11:22am

Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research

Post date: December 18, 2023 - 4:22pm

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Post date: November 22, 2023 - 12:15pm

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Post date: October 26, 2023 - 11:44am

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Post date: October 11, 2023 - 3:40pm

Sapio Sciences launches new drug discovery platform

Post date: October 9, 2023 - 1:50pm

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Post date: October 8, 2023 - 6:05pm

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Post date: October 6, 2023 - 1:27pm

Pages